Zauderer, M. G., Alley, E. W., Bendell, J., Capelletto, E., Bauer, T. M., Callies, S., . . . Varghese, A. M. (2021). Phase 1 cohort expansion study of LY3023414, a dual PI3K/mTOR inhibitor, in patients with advanced mesothelioma. Invest New Drugs.
Chicago-стиль цитированияZauderer, Marjorie G., et al. "Phase 1 Cohort Expansion Study of LY3023414, a Dual PI3K/mTOR Inhibitor, in Patients With Advanced Mesothelioma." Invest New Drugs 2021.
MLA-цитированиеZauderer, Marjorie G., et al. "Phase 1 Cohort Expansion Study of LY3023414, a Dual PI3K/mTOR Inhibitor, in Patients With Advanced Mesothelioma." Invest New Drugs 2021.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.